Why is Unum stock gaining in after-hours trading today?

Unum Group (UNM) reported Q3 2026 earnings, beating estimates with adjusted EPS of $2.17–$2.18, despite a GAAP net loss of $419.7M due to one-time charges. The company reaffirmed its outlook and maintained a $1B share buyback program. Analysts have a consensus price target of $102.15, with 13 Buy ratings. The stock held firm in after-hours trading.

Original reporting
Published Nov 3, 2026, 9:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UNM
Bullish
high confidence
Mentioned
$UNM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$UNMBullishMed
01

Why it matters

Earnings beat and reaffirmed outlook provide a short‑term buying opportunity, though one‑time losses temper enthusiasm.

02

Market read

The earnings surprise may drive after‑hours price stability and modest upside in the near term.

03

What to watch

Potential revenue decline sequentially and future claim trends may dampen upside.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Unum's Q3 earnings were released after market close, with analysts previously expecting modest EPS growth.

Company-level read

Ticker impact

$UNMBullishHigh confidence
Context

Unum reported Q3 2026 earnings, beating consensus EPS and reaffirming outlook, with a net loss of $419.7M but adjusted earnings beat expectations.

Expected impact

likely modest upward pressure as investors price in the earnings beat and share repurchase

Evidence & confidence

The beat on adjusted EPS and reaffirmed guidance, plus a $1B buyback, provide a clear catalyst for short‑term buying.

Market effects

Insurance sector may see modest support from Unum's results and buyback, reinforcing recent analyst upgrades.

U.S. markets likely see slight positive bias in the health insurance niche.

Limited to U.S. insurers; no broader global impact.

Counterpoint

The net loss and one‑time reinsurance charges could signal deeper earnings weakness if recurring.

Key entities

  • Unum Group

    Workplace benefits insurer reporting Q3 2026 results.

Related articles

$UNMMed

Unum Group Stocks Climb 5.19% After JPMorgan Upgrade to Overweight

Unum Group (NYSE:UNM) shares rose 5.19% to $80.74 after JPMorgan upgraded it to Overweight, lowering its price target to $90. The firm cited attractive risk/reward despite lower estimates. Unum reported a Q3 net loss of $2.65 per share due to a $853 million investment loss, but adjusted operating income was $2.20 per share. Core premiums grew 4.7%, while US sales fell 8.5%. The company expects full-year adjusted operating income of $8.30 to $8.50 per share.

$UNMHigh

Unum Group Q3 Earnings Call Highlights

Unum Group (UNM) reported Q3 earnings, noting long-term disability claims 10% above expectations, driven by behavioral health. The company is implementing double-digit rate increases and expects full-year 2026 earnings of $8.30-$8.50 per share. Unum also completed a reinsurance transaction, reducing long-term care exposure by over 40%.

$UNMMedAI 8/10

Unum Group (UNM) (Q3 2026) Earnings Call Highlights: Disability Claims Surge Weighs

Unum Group (UNM) reported Q3 2026 earnings with mixed results. Core premiums grew 5%, and the company returned $1B to shareholders. However, earnings per share of $2.20 missed expectations due to higher disability claims. The group disability benefit ratio rose to 70.6%, and the full-year EPS outlook was revised to $8.30-$8.50. Management attributed the increase in claims to behavioral health issues and expects pricing actions to address the trend.

$UNMHighAI 9/10

Why is Unum stock crashing today?

Unum Group (UNM) stock fell 18.7% to $74.03 after reporting a Q3 2026 GAAP net loss of $419.7M, revenue shortfall of $360M, and adjusted EPS decline of 21%. Barclays cut its price target to $101. The drop is attributed to reinsurance-related charges, rising disability claims, and market focus on earnings deterioration.